Form 3 BlackRock Health Science For: Jul 01 Filed by: Wasserman Aaron David

Go back to Form 3 BlackRock Health Science For: Jul 01 Filed by: Wasserman Aaron David

BlackRock (BLK) an "attractive way to play surge of fixed income inflows' - Keefe, Bruyette & Woods

July 10, 2023 1:19 PM EDT

Keefe, Bruyette & Woods upgraded shares of BlackRock (NYSE: BLK) to Outperform from Market Perform, raising the price target to $835 from $770 in a note to clients Monday.

The firm's analyst Michael Brown said the upgrade is in part due to the fact... More